Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
8.30
-0.36 (-4.16%)
Sep 12, 2025, 4:00 PM EDT - Market closed
Enanta Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
Cash & Equivalents | 44.81 | 37.23 | 85.39 | 43.99 | 57.21 | 87.13 | Upgrade |
Short-Term Investments | 159.3 | 210.95 | 284.52 | 205.24 | 186.8 | 299.52 | Upgrade |
Cash & Short-Term Investments | 204.11 | 248.19 | 369.91 | 249.23 | 244 | 386.65 | Upgrade |
Cash Growth | -11.29% | -32.91% | 48.42% | 2.14% | -36.89% | 15.34% | Upgrade |
Accounts Receivable | 8.33 | 6.65 | 8.61 | 20.32 | 23.58 | 23.49 | Upgrade |
Other Receivables | 0.02 | 32 | 31 | 28.72 | 37.26 | 13.04 | Upgrade |
Receivables | 8.36 | 38.65 | 39.62 | 49.04 | 60.83 | 36.53 | Upgrade |
Prepaid Expenses | 10.24 | 12.41 | 13.26 | 13.45 | 14.19 | 13.66 | Upgrade |
Restricted Cash | - | 0.61 | - | - | - | - | Upgrade |
Total Current Assets | 222.71 | 299.85 | 422.79 | 311.71 | 319.02 | 436.84 | Upgrade |
Property, Plant & Equipment | 74.87 | 73.35 | 34.71 | 29.75 | 10.65 | 15.62 | Upgrade |
Long-Term Investments | - | - | - | 29.29 | 108.42 | 32.63 | Upgrade |
Long-Term Deferred Tax Assets | - | - | - | - | - | 0.35 | Upgrade |
Other Long-Term Assets | 3.45 | 3.45 | 4.77 | 4.66 | 0.7 | 0.7 | Upgrade |
Total Assets | 301.03 | 376.65 | 462.28 | 375.41 | 438.79 | 486.13 | Upgrade |
Accounts Payable | 3.55 | 8 | 4.1 | 6 | 9.54 | 5.74 | Upgrade |
Accrued Expenses | 10.85 | 13.55 | 18.34 | 20.94 | 22.43 | 14.16 | Upgrade |
Current Portion of Long-Term Debt | 27.76 | 34.46 | 35.08 | - | - | - | Upgrade |
Current Portion of Leases | 2.39 | 1.52 | 5.28 | 2.89 | 4.2 | 4.26 | Upgrade |
Total Current Liabilities | 44.55 | 57.54 | 62.79 | 29.83 | 36.17 | 24.16 | Upgrade |
Long-Term Debt | 121.29 | 136.13 | 160.85 | 1.42 | 1.51 | 1.48 | Upgrade |
Long-Term Leases | 55.66 | 53.94 | 21.24 | 22.37 | 1.13 | 3.84 | Upgrade |
Other Long-Term Liabilities | 0.25 | 0.23 | 0.66 | 0.45 | 0.56 | 1.08 | Upgrade |
Total Liabilities | 221.75 | 247.84 | 245.54 | 54.08 | 39.36 | 30.55 | Upgrade |
Common Stock | 0.21 | 0.21 | 0.21 | 0.21 | 0.2 | 0.2 | Upgrade |
Additional Paid-In Capital | 465.7 | 451.34 | 424.69 | 398.03 | 351.03 | 326.96 | Upgrade |
Retained Earnings | -386.23 | -323.04 | -207 | -73.18 | 48.58 | 127.57 | Upgrade |
Comprehensive Income & Other | -0.4 | 0.3 | -1.17 | -3.72 | -0.38 | 0.84 | Upgrade |
Shareholders' Equity | 79.28 | 128.81 | 216.74 | 321.33 | 399.43 | 455.58 | Upgrade |
Total Liabilities & Equity | 301.03 | 376.65 | 462.28 | 375.41 | 438.79 | 486.13 | Upgrade |
Total Debt | 207.1 | 226.06 | 222.44 | 26.69 | 6.84 | 9.58 | Upgrade |
Net Cash (Debt) | -2.99 | 22.13 | 147.47 | 251.83 | 345.58 | 409.71 | Upgrade |
Net Cash Growth | - | -85.00% | -41.44% | -27.13% | -15.65% | 2.86% | Upgrade |
Net Cash Per Share | -0.14 | 1.05 | 7.03 | 12.22 | 17.13 | 20.55 | Upgrade |
Filing Date Shares Outstanding | 21.38 | 21.19 | 21.06 | 20.8 | 20.32 | 20.08 | Upgrade |
Total Common Shares Outstanding | 21.38 | 21.19 | 21.06 | 20.79 | 20.24 | 20.08 | Upgrade |
Working Capital | 178.16 | 242.32 | 360 | 281.89 | 282.85 | 412.68 | Upgrade |
Book Value Per Share | 3.71 | 6.08 | 10.29 | 15.46 | 19.74 | 22.69 | Upgrade |
Tangible Book Value | 79.28 | 128.81 | 216.74 | 321.33 | 399.43 | 455.58 | Upgrade |
Tangible Book Value Per Share | 3.71 | 6.08 | 10.29 | 15.46 | 19.74 | 22.69 | Upgrade |
Machinery | 20.36 | 19.92 | 19.14 | 16.79 | 16.32 | 15.82 | Upgrade |
Construction In Progress | 1.35 | 22.75 | 1.27 | 2.56 | 0.02 | - | Upgrade |
Leasehold Improvements | 36.82 | 13.98 | 13.8 | 7.28 | 7.14 | 7.09 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.